Wang Z, Tan W, Huang J, Zhang P, Li Q, Wang M
J Inflamm Res. 2025; 18():33-51.
PMID: 39780983
PMC: 11708204.
DOI: 10.2147/JIR.S487185.
Scarpignato C, Hunt R
Curr Gastroenterol Rep. 2024; 26(11):273-293.
PMID: 39145848
PMC: 11401795.
DOI: 10.1007/s11894-024-00939-3.
Liu Y, Gao Z, Hou X
Therap Adv Gastroenterol. 2024; 17:17562848241251567.
PMID: 38903448
PMC: 11189022.
DOI: 10.1177/17562848241251567.
Song S, Zhang Y, Zhang J, Jiang Y, Gong A
Medicine (Baltimore). 2024; 103(24):e38045.
PMID: 38875370
PMC: 11175940.
DOI: 10.1097/MD.0000000000038045.
Cai Z, Mu M, Ma Q, Liu C, Jiang Z, Liu B
Cochrane Database Syst Rev. 2024; 2:CD015014.
PMID: 38421211
PMC: 10903295.
DOI: 10.1002/14651858.CD015014.pub2.
Current complementary and alternative therapy forgastroesophageal reflux disease.
Jiang D, Zhuang Q, Jia X, Chen S, Tan N, Zhang M
Gastroenterol Rep (Oxf). 2023; 11:goad057.
PMID: 37810946
PMC: 10551227.
DOI: 10.1093/gastro/goad057.
Clinical relevance of salivary pepsin detection in diagnosing gastroesophageal reflux disease subtypes.
Zhang M, Wu T, Tan N, Chen S, Zhuang Q, Luo Y
Gastroenterol Rep (Oxf). 2023; 11:goad053.
PMID: 37720194
PMC: 10500079.
DOI: 10.1093/gastro/goad053.
The brain-esophagus axis in subjects with and without obesity assessed by esophageal acid perfusion and functional brain imaging.
Ribeiro M, Forcelini C, Jr J, Soder R, Fornari F
Ann Gastroenterol. 2023; 36(5):504-510.
PMID: 37664237
PMC: 10433251.
DOI: 10.20524/aog.2023.0818.
Predicting reflux symptom recurrence: The impact of gastroesophageal junction indicators and body mass index among outpatients.
Wang Q, Lu J, Sui Y, Fan J, Ren J, Wang Z
Exp Ther Med. 2023; 26(1):351.
PMID: 37324506
PMC: 10265715.
DOI: 10.3892/etm.2023.12050.
The long-term efficacy of transoral incisionless fundoplication with Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease.
Shen S, Yu G, Guo X, Zong G, Wang C, Bao J
Esophagus. 2023; 20(3):581-586.
PMID: 36877412
PMC: 10234897.
DOI: 10.1007/s10388-023-00992-3.
Clinical outcomes of asymptomatic low-grade esophagitis: results from a multicenter Chinese cohort.
Chen S, Xiang X, Zhang X, Zhuang Q, Tan N, Hou X
Gastroenterol Rep (Oxf). 2022; 10:goac057.
PMID: 36263392
PMC: 9562142.
DOI: 10.1093/gastro/goac057.
Mean Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index Could Identify Gastroesophageal Reflux Disease but pH-Impedance Metrics Alone Might Not Correlate With Proton Pump Inhibitor Response in Chinese Patients With....
Wang D, Duan C, Zhang X, Xu J, Hou X, Xiang X
J Neurogastroenterol Motil. 2022; 28(4):580-588.
PMID: 36250365
PMC: 9577582.
DOI: 10.5056/jnm21156.
The role of vonoprazan in patients with erosive esophagitis.
Zhang M, Xiao Y, Chen M
Therap Adv Gastroenterol. 2022; 15:17562848221122623.
PMID: 36117573
PMC: 9478709.
DOI: 10.1177/17562848221122623.
Cost-Utility Analysis of CYP2C19 Genotype Detection for Selection of Acid-Suppressive Therapy with Lansoprazole or Vonoprazan for Patients with Reflux Esophagitis in China.
Zhang Z, Bao Y, Cai L, Gu Y, Yang T, Li X
Clin Drug Investig. 2022; 42(10):839-851.
PMID: 35994227
DOI: 10.1007/s40261-022-01188-w.
Validity of a Soft and Flexible 3D-Printed Nissen Fundoplication Model in Surgical Training.
Zhang Y, Xia J, Zhang J, Mao J, Chen H, Lin H
Int J Bioprint. 2022; 8(2):546.
PMID: 35669328
PMC: 9159478.
DOI: 10.18063/ijb.v8i2.546.
Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China.
Wang Z, Sun R, Sheng Y, Qu S, Dong L, Wu B
Ann Transl Med. 2022; 10(8):480.
PMID: 35571388
PMC: 9096411.
DOI: 10.21037/atm-22-1722.
